Top Markets
Coin of the day
Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.

AVTE
株式のランク #5459
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise... Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise focused on innovating therapies to enhance the well-being of patients afflicted with rare cardiopulmonary illnesses across the United States. The company's principal effort involves advancing AV-101, an inhaled dry powder variant of imatinib, which is currently undergoing a Phase 2b/Phase 3 clinical study for the management of pulmonary arterial hypertension. Established in 2018, Aerovate Therapeutics, Inc. maintains its corporate headquarters in Waltham, Massachusetts.
株価
$93.80
最終同期: 2025-04-28
時価総額
$2.68B
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Aerovate Therapeutics, Inc. (AVTE)

カテゴリー

Aerovate Therapeutics, Inc.(AVTE)の配当履歴
Aerovate Therapeutics, Inc.(証券コード:AVTE)は合計で1回の配当を行いました。
すべての配当の合計(株式分割調整済み)は:$2.40
配当利回り(TTM):0
2025から2026までのAerovate Therapeutics, Inc.(AVTE)の配当履歴
年間配当支払い
配当(株式分割調整済み) 変化
2026 (TTM) $2.40 0.00%
2025 $2.40 0.00%
すべての配当支払いの一覧
配当 変化
2026 (TTM) $84.00 0.00%
2025 $84.00 0.00%
同業他社や競合企業の配当履歴
企業 配当支払い回数
0.00%
US
0.00%
NL
0.00%
US
64.00%
AU
0.00%
CH